Decreased pulmonary extracellular superoxide dismutase during systemic inflammation
Decreased pulmonary extracellular superoxide dismutase during systemic inflammation
复制标题
DOI:
10.1016/j.freeradbiomed.2008.06.016
复制
发表时间:
2008-09-15
影响因子:
7.4
通讯作者:
Saito, Hiroshi
中科院分区:
文献类型:
--
作者:
Ueda, Junji;Starr, Marlene E.;Saito, Hiroshi
Oxidative damage is a major cause Of lung injury during systemic inflammatory response syndrome. In this Study, the expression of an antioxidant enzyme, extracellular superoxide dismutase (EC-SOD) and its, protective role against Pulmonary oxidative damage were investigated using Mouse models of systemic inflammation. Intraperitoneal injection with bacterial endotoxin lipopolysaccharides (LPS; 20 mg/kg) caused oxidative damage in lungs as assessed by increased tyrosine nitration in proteins. LPS administration also resulted in a rapid and significant loss of more than 80% of pulmonary EC-SOD in a time- and dose-dependent manner, but other types of SODs, cytoplasmic CuZn-SOD and mitochondrial Mn-SOD were not, affected. EC-SOD protein is most abundant in lungs but also present at high levels in other tissues such as heart and white fat: however, the LPS-mediated decrease in this enzyme was most apparent in the lungs. Intravenous injection of mice with tumor necrosis factor alpha (10 mu g per mouse) also caused a 60% decrease in EC-SOD in the lungs, suggesting that the EC-SOD down-regulation is mediated by this LPS-inducible inflammatory cytokine. A protective role for EC-SOD against LPS-mediated systemic inflammation was shown by an increased survival rate (75% vs 29% in 5 days) and decreased pulmonary oxidative damage in EC-SOD transgenic mice that overexpress the human EC-SOD gene. These results demonstrate that the inflammation-mediated EC-SOD down-regulation has a major pathophysiological impact during the systemic inflammatory response syndrome. (C) 2008 Elsevier Inc. All rights reserved.